Search by Title Article Topic - Any -AdvocacyCertificationClinical TrialsCoronavirusEarly CareerFellowshipFuture LeadersHeart Failure Awareness 365Heart Failure GuidelinesHFSA Annual Scientific MeetingHFSA AwardsHFSA Board Certification ReviewHFSA CommitteesHFSA Comprehensive Heart Failure ReviewHFSA Learning CenterHFSA MembershipIn The NewsIndustryJournal of Cardiac FailureMentorshipNursingPartnersPatient ResourcePodcastsPresident's UpdatesPress ReleaseProfessional DevelopmentProvider EducationResearchSocial MediaSubmissionsWomen in Heart Failure Article Type - Any -HFSA NewsIndustry NewsPatient NewsPractice News Jan 22 2021 | HFSA to Release Three Episodes of Patient Podcast, Heart Failure Beat Healthy Living, During Heart Failure Awareness Week 2021 HFSA News Heart Failure Awareness 365 Read More Jan 21 2021 | Dr. Barry Massie, Past President of the Heart Failure Society of America, Passes HFSA News In The News Read More Jan 18 2021 | Heart Failure Awareness 365: Research, Clinical Trials, and Patient Advocacy Patient News Heart Failure Awareness 365 Patient Resource Read More Jan 13 2021 | US FDA accepts supplemental New Drug Application for Jardiance® (empagliflozin) for adults with heart failure with reduced ejection fraction Industry News In The News Industry Read More Jan 10 2021 | HFSA President's Update: January 2021 HFSA News President's Updates Read More Pagination First page « First Previous page ‹ Previous … Page 5 Page 6 Page 7 Page 8 Current page 9 Page 10 Page 11 Page 12 Page 13 … Next page Next › Last page Last »
Jan 22 2021 | HFSA to Release Three Episodes of Patient Podcast, Heart Failure Beat Healthy Living, During Heart Failure Awareness Week 2021 HFSA News Heart Failure Awareness 365 Read More
Jan 21 2021 | Dr. Barry Massie, Past President of the Heart Failure Society of America, Passes HFSA News In The News Read More
Jan 18 2021 | Heart Failure Awareness 365: Research, Clinical Trials, and Patient Advocacy Patient News Heart Failure Awareness 365 Patient Resource Read More
Jan 13 2021 | US FDA accepts supplemental New Drug Application for Jardiance® (empagliflozin) for adults with heart failure with reduced ejection fraction Industry News In The News Industry Read More
